Although adolescents and young adults comprise only one quarter of the sexually active population in the United States, ...
Real-world data show DoxyPEP implementation among PrEP users significantly reduces the incidence of chlamydia and syphilis.
Among individuals using HIV pre-exposure prophylaxis (HIV PrEP), doxycycline post-exposure prophylaxis (doxyPEP) was associated with a substantial decline in chlamydia and syphilis incidence.
Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis who were prescribed preexposure prophylaxis (PrEP), a preventative ...
A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...
HIV pre-exposure prophylaxis (PrEP) is an effective and safe intervention for individuals with behaviors that are considered high risk for acquiring HIV infection. Despite the success of this ...
Health and Human Rights, Vol. 24, No. 1, SPECIAL SECTION: Compulsory Drug Treatment and Rehabilitation, Health, and Human Rights (JUNE 2022), pp. 105-116 (12 pages) This paper examines the extent to ...
Pre-exposure prophylaxis (PrEP) is a medication regimen that is used to protect at-risk populations from HIV infection. The FDA approved the drug TRUVADA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results